Whole-Brain Radiotherapy Can Improve the Survival of Patients with Multiple Brain Metastases from Non-Small Cell Lung Cancer Treated by Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors

OBJECTIVE: To observe whether whole-brain radiotherapy (WBRT) can bring survival benefits to patients with multiple brain metastases (BM) from non-small cell lung cancer (NSCLC) treated by epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) and determine the best time for WBRT in...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Cheng, Wu, Yan, Liu, Bao Ling, Wang, Hong Wei, Ma, Jian Hua, Zhou, Ju Ying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7654538/
https://www.ncbi.nlm.nih.gov/pubmed/33192093
http://dx.doi.org/10.2147/CMAR.S279096

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7654538/
https://www.ncbi.nlm.nih.gov/pubmed/33192093
http://dx.doi.org/10.2147/CMAR.S279096

Ejemplares similares